SOURCE: iData Research

iData Research

May 05, 2016 07:00 ET

Changes to Medicare Continue to Drive Growth in U.S. Catheter Securement Devices Market

In 2015, the Total Vascular Access Device Market Was Worth Almost $4 Billion

VANCOUVER, BC--(Marketwired - May 05, 2016) - According to a new series of reports on the U.S. vascular access device and accessories market by iData Research (, the catheter securement market is expected to grow over the forecast period. The catheter securement market is dominated by tape and dressings, and though manufactured catheter securement devices (MCSDs) and sutures make up a part, it is a smaller portion of this market.

Tapes and dressings have traditionally been the dominant segments in this market, holding a vast majority of unit share. This is due to their relatively low average selling price, their use across different medical applications and their increasing number of units sold. However, sutures and MCSDs do still have their practical applications in a clinical setting. In fact, MCSDs are one of the fastest growing segments in the entire U.S. vascular access device market. The growth of MCSDs is likely due to the fact that since 2008 catheter-related infections in the U.S. are no longer reimbursed by Medicare. The infection rate after securing catheters with MCSDs is much lower than other devices, driving the growth of this segment.

The catheter securement device market is expected to grow at a strong rate, driven by an increase in unit sales and average selling prices across all segments. With the reimbursement changes to Medicare, there will be a greater need for MCSDs and antimicrobial securement products. These products are more expensive, thus pushing the average selling prices up. Increased rates of catheter placements in the U.S. will also drive up unit sales.

"Nurses and doctors strongly support the use of devices that will reduce catheter complications," explains Dr. Kamran Zamanian, CEO of iData, "Despite their high price; the market will increasingly adopt safer catheter securement devices over the forecast period."

The number of catheter placements in the U.S. is steadily increasing. As the population ages and more patients are affected by end-stage renal disease, diabetes and cancer, among others, there will be a greater need for catheters thus increasing the rate of placement. Additionally, as the rate of placement increases, there is significant motivation to reduce instances of infections and complications.

In 2015, the market for catheter securement devices was led by 3M. The company leads the market mainly due to strong representation in the dressings segment. Their dressing Tegaderm™, introduced in 2008, provides antimicrobial protection. They also market several other dressing types. Johnson & Johnson was the second-leading competitor in 2015 and they are strong in the suture segment. They also market foam dressings, and while not offering securement, can help prevent catheter-related bloodstream infections. Other notable competitors include Smith & Nephew, Covidien and others.

For Further Information

More on the catheter securement device market can be found in a report suite published by iData Research entitled the U.S. Vascular Access Device and Accessories Market. The suite covers market reports on implantable ports, port needles, central venous catheters, peripherally inserted central catheters, peripheral intravenous catheters, dialysis catheters, ultrasound vascular access device and accessories, syringes and needles.

Reports also provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, competitor SWOTs, disease overviews, product pipelines, press releases, as well as detailed competitive market shares and analysis of major players' success strategies in each market and segment. To find out more on vascular access device and accessories market data or procedure data, register online or email us at for a U.S. Vascular Access Device and Accessories Market brochure and synopsis.

About iData Research

iData Research ( is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Vascular Access, Peripheral Vascular, Endoscopy, Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management, Electrophysiology, X-Ray Imaging, Diagnostic Imaging, Operating Room Equipment, Surgical Microscopes, Robotics and Surgical Navigation, Oncology, Ultrasound, Laparoscopy, Urology, Gynecology, Spinal Implants and VCF, Spinal MIS, Orthopedic Soft Tissue Repair and Regeneration, Orthopedic Trauma, Large & Small Joints, Anesthesiology, Wound Management, Orthopedics, Ophthalmics, Dental Operatory Equipment and more.

Contact Information